Analyst Conference Summaries

Biotechnology Investor Aids

Recursion
RXRX

conference date: August 5, 2025 @ 5:00 AM Pacific Time

2025
Recursion
Q1 2025
Recursion
Q2 2025
   
May 5, 2025 August 5, 2025    

Recursion (RXRX) is a clinical-stage biotechnology company specializing in using machine learning algoriths to discover potential new drug therapies. Lead candidates include REC-617 and REC-4881.

Recursion web site


 

Search

More Analyst Conference Pages:

 AGEN
 AGIO
 ALLO
 ALNY
 AMAT
 AMGN
 APRE
 ARWR
 BIIB
 BLRX
 BMY
 BOLD
 CCCC
 CLDX
 CBIO
 BMY
 FATE
 GILD
 GLYC
 ILMN
 INO
 IONS
 LGND
 MCHP
 MRNA
 REGN
 RNA
 RXRX
 SAGE
 SANA
 SUPN
 VRTX
 VSTM
       

Disclaimer: My analyst summaries may include both condensations of statements made by company representatives and my own analysis. They are not covered by any warranty. I cannot guarantee anything said by company representatives is true. I try not to make errors, but it is possible. These are my personal notes which I share with other investors and which I use as the basis of my blog and Seeking Alpha articles.

Copyright 2025 William P. Meyers